Immunometabolic regulation in natural HIV-1 control
Author: Sperk, Maike
Date: 2022-05-20
Location: 4U Solen, ANA Futura, Alfred Nobels allé 8, Karolinska Institutet, Flemingsberg
Time: 10.00
Department: Inst för laboratoriemedicin / Dept of Laboratory Medicine
View/ Open:
Thesis (9.874Mb)
Abstract
The elite controllers (EC) are a rare group of people living with HIV-1 infection (PLHIV) that can control viral replication in the absence of antiretroviral therapy for a prolonged time. The mechanisms behind elite control phenotype leading to viral suppression are not fully elucidated. It has also become clear that molecules function in complex and interconnected networks shaping the phenotype of a cell, tissue, or organism. The advancements made in high- throughput technologies and in computational methods enable the investigation of a large set of molecules simultaneously allowing to fingerprint the cross-talks and dynamics of these molecules.
The work presented in this thesis aimed to unravel the immuno-metabolic regulation in PLHIVEC using a data-driven approach where untargeted metabolomics, proteomics and microbiome profiling were applied in combination with targeted immunological and other assays. We observed that PLHIVEC had a distinct plasma and fecal metabolic signature compared to treatment-naïve HIV-1-positive viremic progressors (PLHIVVP) and HIV- negative individuals (HC). Low-level inflammation and antioxidant defense mechanisms at physiological levels seen in plasma and blood cells, together with increased fecal levels of dipeptides and the bacterial genus Prevotella are proposed to be important factors involved in natural control of HIV-1. Furthermore, a unique signature of chemokine receptor expression on immune cells and a specific proteomic profile of CD4+ T cells indicative of a modulated energy metabolism may also play a role in EC phenotype. Altogether these features are suggested to create an unfavorable environment for HIV-1 replication and thus contribute to natural control of the virus.
The work presented in this thesis aimed to unravel the immuno-metabolic regulation in PLHIVEC using a data-driven approach where untargeted metabolomics, proteomics and microbiome profiling were applied in combination with targeted immunological and other assays. We observed that PLHIVEC had a distinct plasma and fecal metabolic signature compared to treatment-naïve HIV-1-positive viremic progressors (PLHIVVP) and HIV- negative individuals (HC). Low-level inflammation and antioxidant defense mechanisms at physiological levels seen in plasma and blood cells, together with increased fecal levels of dipeptides and the bacterial genus Prevotella are proposed to be important factors involved in natural control of HIV-1. Furthermore, a unique signature of chemokine receptor expression on immune cells and a specific proteomic profile of CD4+ T cells indicative of a modulated energy metabolism may also play a role in EC phenotype. Altogether these features are suggested to create an unfavorable environment for HIV-1 replication and thus contribute to natural control of the virus.
List of papers:
I. Sperk M, Mikaeloff F, Svensson-Akusjärvi S, Krishnan S, Ponnan SM, Ambikan AT, Nowak P, Sönnerborg A, Neogi U. Distinct lipid profile, low- level inflammation, and increased antioxidant defense signature in HIV-1 elite control status. iScience. 2021; 24(2): 102111.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Sperk M, Ambikan AT, Ray S, Singh K, Mikaeloff F, Diez RC, Narayanan A, Vesterbacka J, Nowak P, Sönnerborg A, Neogi U. Fecal Metabolome Signature in the HIV-1 Elite Control Phenotype: Enrichment of Dipeptides Acts as an HIV-1 Antagonist but a Prevotella Agonist. J Virol. 2021; 95(18): e0047921.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Svensson Akusjärvi S, Krishnan S, Jütte BB, Ambikan AT, Gupta S, Rodriguez JE, Végvári Á, Sperk M, Nowak P, Vesterbacka J, Svensson JP, Sönnerborg A, Neogi U. Peripheral blood CD4+CCR6+ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals. Communications Biology. 2022; 5(1): 357.
Fulltext (DOI)
Pubmed
I. Sperk M, Mikaeloff F, Svensson-Akusjärvi S, Krishnan S, Ponnan SM, Ambikan AT, Nowak P, Sönnerborg A, Neogi U. Distinct lipid profile, low- level inflammation, and increased antioxidant defense signature in HIV-1 elite control status. iScience. 2021; 24(2): 102111.
Fulltext (DOI)
Pubmed
View record in Web of Science®
II. Sperk M, Ambikan AT, Ray S, Singh K, Mikaeloff F, Diez RC, Narayanan A, Vesterbacka J, Nowak P, Sönnerborg A, Neogi U. Fecal Metabolome Signature in the HIV-1 Elite Control Phenotype: Enrichment of Dipeptides Acts as an HIV-1 Antagonist but a Prevotella Agonist. J Virol. 2021; 95(18): e0047921.
Fulltext (DOI)
Pubmed
View record in Web of Science®
III. Svensson Akusjärvi S, Krishnan S, Jütte BB, Ambikan AT, Gupta S, Rodriguez JE, Végvári Á, Sperk M, Nowak P, Vesterbacka J, Svensson JP, Sönnerborg A, Neogi U. Peripheral blood CD4+CCR6+ compartment differentiates HIV-1 infected or seropositive elite controllers from long-term successfully treated individuals. Communications Biology. 2022; 5(1): 357.
Fulltext (DOI)
Pubmed
Institution: Karolinska Institutet
Supervisor: Neogi, Ujjwal
Co-supervisor: Nowak, Piotr; Domselaar, Robert van
Issue date: 2022-04-28
Rights:
Publication year: 2022
ISBN: 978-91-8016-504-4
Statistics
Total Visits
Views | |
---|---|
Immunometabolic ... | 283 |
Total Visits Per Month
October 2023 | November 2023 | December 2023 | January 2024 | February 2024 | March 2024 | April 2024 | |
---|---|---|---|---|---|---|---|
Immunometabolic ... | 10 | 14 | 7 | 4 | 22 | 5 | 3 |
File Visits
Views | |
---|---|
Thesis_Maike_Sperk.pdf | 296 |
Top country views
Views | |
---|---|
Sweden | 61 |
United States | 47 |
Ireland | 31 |
South Africa | 24 |
Germany | 15 |
China | 9 |
Russia | 8 |
South Korea | 7 |
United Kingdom | 6 |
France | 4 |
Top cities views
Views | |
---|---|
Dublin | 30 |
Pretoria | 20 |
Ashburn | 8 |
Stockholm | 8 |
Västerås | 6 |
Moscow | 5 |
San Mateo | 5 |
Umeå | 5 |
Bromma | 4 |
Hanoi | 3 |